Abstract:e18084 Background: Previous studies indicated the carcinoembryonic antigen (CEA) could predict the therapeutic objective response (OR) and overall survival (OS) of patients with cancers, including non-small cell lung cancer (NSCLC). However, the role it could play in evaluating therapeutic responses and OS in patients with NSCLC requires further elucidation. Herein, we investigated the potential role of CEA in predicting OR and OS in patients with NSCLC. Methods: 689 patients with NSCLC were enrolled between January 2000 and August 2011. The correlations between the CEA levels and OR or OS were examined via statistical analyses including the chi-squared test, logistical regression, paired-samples t-test, receiver operator characteristic curve, Kaplan-Meier survival analysis, log-rank test and Cox regression model. Results: The calculated cut-off for predicting an OR to chemotherapy in patients with NSCLC was a reduction of 5.28% in serum CEA. This value demonstrated a sensitivity of 61.3% and a specificity of 62.4%. Serum CEA levels significantly decreased after two cycles of chemotherapy in NSCLC patients (t = 2.196, P = 0.031). The Kaplan-Meier survival analysis indicated no significant correlation between baseline CEA and OS (log rank test =0.079). However, according to the Cox regression analysis the number of distant metastatic organs (=1 and ≥2) was the independent risk factor of the OS (P = 0.026; P =0.003), and the cycle numbers of chemotherapy was the protective factor for OS in patients with NSCLC (P=0.011).More importantly, baseline serum CEA was significantly associated with lung adenocarcinoma and adenosquamous subtypes (P = 0.014; P = 0.017, respectively). Conclusions: Our study shows that baseline serum CEA was significantly associated with lung adenocarcinoma and adenosquamous subtypes. While the baseline level of serum CEA was not a prognostic factor, the post-treatment reduction of serum CEA level can predict the OR in patients with NSCLC,. The number of chemotherapy cycles was the independent protective factor, while the numbers of distant metastatic organs was the independent risk factor for NSCLC patients’ OS.

Correlation Between Carcinoembryonic Antigen (CEA) Expression and EGFR Mutations in Non-Small-cell Lung Cancer: a Meta-Analysis.

EGFR Mutations in Correlation with the Tumor Markers in NSCLC Patients

Carcinoembryonic Antigen in Pleural Effusion of Patients with Lung Adenocarcinoma: a Predictive Marker for EGFR Mutation

Expression and Prognostic Relevance of Tumor Carcinoembryonic Antigen in Stage IB Non-Small Cell Lung Cancer.

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma

The value of carcinoembryonic antigen levels in non-small cell lung cancer patients treated with EGFR-TKI

Expression And Prognostic Relevance Of Tumor Carcinoembryonic Antigen In Stage Ib Non-Small Cell Lung Cancer

High Expression Of Serum Carcinoembryonic Antigen (Cea) Associated With Poor Prognosis In Early Gastric Cancer: A Single-Center Retrospective Study

[Immunohistochemical study of carcinoembryonic antigen (CEA) in non small cell carcinomas of the lung and bronchial epithelium adjacent to tumors].

Prediction of Epidermal Growth Factor Receptor Mutations in the Plasma/pleural Effusion to Efficacy of Gefitinib Treatment in Advanced Non-Small Cell Lung Cancer.

Cmar_a_246566 2767..2775

The Prognostic Significance of Pretreatment Serum Cea Levels in Gastric Cancer: A Meta-Analysis Including 14651 Patients

Correlation Between Efficacy of the EGFR Tyrosine Kinase Inhibitor and Serum Tumor Markers in Lung Adenocarcinoma Patients

Combined Detection of Preoperative Neutrophil-To-Lymphocyte Ratio and Cea As an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection is Superior to Nlr or Cea Alone

The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer

CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis

[Clinicopathological Features Associated with EGFR Gene Mutation in Non-Small Cell Lung Cancer Patients].

Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.

Measurement and clinical implication of circulating antibodies against carcinoembryonic antigen in patients with colorectal carcinoma

Diagnostic and Prognostic Value of Carcinoembryonic Antigen in Pancreatic Cancer: a Systematic Review and Meta-Analysis

The Role of Serum Carcinoembryonic Antigen in Predicting Responses to Chemotherapy and Survival in Patients with Non-Small Cell Lung Cancer